The Evolving Landscape of Amyloid Research
1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California, USA.
Proteins
|August 28, 2025
Summary
This study maps global amyloid research using AI and bibliometrics, revealing trends in subfields, authors, and topics over time. It offers insights into the evolution of amyloid biology and identifies future research directions.
Area of Science:
- Biomedical and Life Sciences
- Computational Biology
- Bibliometrics
Background:
- Exponential growth in biomedical literature challenges tracking discoveries.
- Artificial intelligence (AI) and natural language models (NLM) enable large-scale analysis of scientific publications.
- Understanding the evolution of specific research fields like amyloid biology is complex.
Purpose of the Study:
- To present a two-dimensional mapping of the global amyloid research landscape.
- To visualize key trends, historical progression, and dominant subfields in amyloid research.
- To identify latent research topics, including chemicals and small molecules, over time.
Main Methods:
- Utilized PubMedBERT, a transformer-based large language model.
- Employed t-SNE and Latent Dirichlet Allocation (LDA) for data analysis.
- Analyzed over 140,000 abstracts from the PubMed database.
Main Results:
- Provided a comprehensive visualization of the amyloid research field.
- Captured historical progression and the emergence of dominant subfields.
- Identified contributing authors, their countries, and latent research topics, including chemicals and small molecules.
Conclusions:
- AI-driven text analysis integrated with bibliometric data offers novel perspectives on amyloid research evolution.
- This study facilitates deeper interdisciplinary understanding of amyloid biology.
- Machine learning-driven literature mapping can identify knowledge gaps and guide future research.
More Related Videos
Related Concept Videos
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666


